PRDM10-DT: A Non-Coding RNA Molecule as A Potential Drug Target

Target Name: PRDM10-DT

NCBI ID: G440072

PRDM10-DT

Other Name(s): C11orf37 | PRDM10 divergent transcript | NCRNA00167 | LINC00167

PRDM10-DT: A Non-Coding RNA Molecule as A Potential Drug Target

PRDM10-DT, also known as C11orf37, is a non-coding RNA molecule that has been identified as a potential drug target or biomarker for various diseases, including cancer. Its unique structure and biological function have made it an attractive target for researchers to study, and recent studies have shed light on its potential role in disease.

PRDM10-DT is a short non-coding RNA molecule that consists of 19 amino acid residues. It is located in the nucleus and has been shown to play a role in various cellular processes, including the regulation of gene expression and the control of cellular processes such as DNA replication and apoptosis.

One of the key features of PRDM10-DT is its ability to interact with other non-coding RNAs, including microRNAs (miRNAs) and long non-coding RNAs (lncRNAs). These interactions are critical for the regulation of gene expression and can help to control the cell's genetic program.

PRDM10-DT has been shown to play a role in the regulation of various gene expression pathways, including the control of cell proliferation and the regulation of cellular processes such as cell adhesion and migration. It has also been shown to interact with proteins that are involved in the regulation of these processes, including the TGF-β pathway.

In addition to its role in gene regulation, PRDM10-DT has also been shown to play a role in the regulation of protein stability and degradation. This is important for the regulation of cellular processes and for the control of protein-protein interactions that are involved in various cellular processes.

The potential drug target status of PRDM10-DT is due to its unique structure and biology, as well as its involvement in various cellular processes that are important for the regulation of gene expression and cellular processes. Its potential as a drug target makes it an attractive target for researchers to study and develop new treatments for various diseases.

In conclusion, PRDM10-DT is a non-coding RNA molecule that has been identified as a potential drug target or biomarker for various diseases. Its unique structure and biology, as well as its involvement in various cellular processes that are important for the regulation of gene expression and cellular processes, make it an attractive target for researchers to study and develop new treatments for a variety of diseases. Further research is needed to fully understand its potential role in disease and to develop effective treatments.

Protein Name: PRDM10 Divergent Transcript

The "PRDM10-DT Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about PRDM10-DT comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets